ASND News Today: Stay Updated with the Latest Ascendis Pharma A/S News in Real Time
Find ASND news now at Meyka AI. Stay informed with the latest Ascendis Pharma A/S stocks updates, including price news, market analysis, and expert insights.
Indian Stock Market Week Closing: Sensex Gains 2.30% to 75,527 as Bulls Eye 76K Resistance Zone
The Indian stock market closed the week on a strong bullish note. The Sensex jumped 2.30% to close at 75,527, marking one of the strongest weekly recoveries in recent sessions. The Nifty also followed the upward trend, supported by heavy buying in financial and blue-chip stocks. We saw strong risk-on sentiment across Dalal Street. Global…
Sun Pharmaceutical (SUNPHARMA) Shares Rise 0.32% as Pharma Giant Announces ₹5 Final Dividend Record Date
Sun Pharmaceutical Industries has once again grabbed investor attention in the Indian stock market. The Sun Pharmaceutical share price rose around 0.32% in recent trading sessions after the company announced a ₹5 final dividend for FY2025-26. The announcement also included key corporate updates, including the upcoming record date for dividend eligibility, which is now in…
Ono Pharma Seeks Japan Approval for OPDIVO Thyroid Cancer Treatment, June 12
Ono Pharma seeks Japan approval for OPDIVO in unresectable anaplastic thyroid cancer after NAVIGATION trial achieved 47.6% response rate.
Alembic Pharmaceuticals Shares Jump 3% After US FDA Tentatively Approves Larotrectinib Capsules
Alembic Pharmaceuticals shares rose nearly 3% in trading after the company announced that the US Food and Drug Administration (FDA) granted tentative approval for its Larotrectinib capsules. The development marks a positive milestone for the Indian pharmaceutical company as it continues to expand its presence in the regulated US market. The announcement triggered strong investor…
Concord Biotech Shares Jump 5.9% After US FDA Approves Tofacitinib Arthritis Drug
Shares of Concord Biotech saw strong buying interest after a key global development. The stock rose around 5.9% in recent trading sessions after news of a US FDA approval related to its Tofacitinib-based arthritis drug. The trigger is important. The US Food and Drug Administration (FDA) approval opens doors to the world’s largest pharmaceutical market….
Top Indian Stocks: Ajanta Pharma, Bharti Airtel, IndiGo Lead Watchlist Amid Global Market Weakness
Indian equities entered the June 10 session with caution as global markets remained under pressure from rising crude oil prices and geopolitical concerns. Despite the weak backdrop, a few key stocks stood out due to major corporate developments, regulatory relief, and ownership changes. Market participants are closely tracking Ajanta Pharma, Bharti Airtel, and IndiGo as…
GSK to Buy Nuvalent for $10.6 Billion, Paying $124 Per Share in All-Cash Deal
GSK has made a major move in the global pharmaceutical industry. The company has agreed to acquire Nuvalent for $10.6 billion in an all-cash deal. The offer price is $124 per share, which is about a 40% premium compared to the last closing price of Nuvalent. This is not a small deal. It is one…
Panacea Biotec Soars 11.89% to 52-Week High After Launch of EU-Funded DENSTAR Project
Panacea Biotec is having its best week in years. The stock surged 11.89% to a fresh 52-week high of ₹619.05 on June 9, 2026, on the NSE, rallying from a 52-week low of ₹293.10, for an 111% climb in under twelve months. The trigger was the official launch of the DENSTAR project, a 48-month, EU-backed…
NIFTY50 Plunges 0.92% on Asia Selloff, Oil Spike, June 08
NIFTY50 drops 0.92% on June 8 as Asian markets crash, crude oil spikes to $96, and geopolitical tensions in West Asia weigh on Indian equities.